Clinical Trials · NCT06908694
Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Hamilton Health Sciences Corporation
- Enrollment
- 20
- Start date
- Jul 2025
- Locations
- 1 site, Canada
- Primary endpoint
- Number of Serious Adverse Events